| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Tienush Rassaf | |
| Peter Luedike | |||
| Christoph Rischpler | |||
| Maria Papathanasiou | |||
| Alexander Carpinteiro | |||
| Tim Hagenacker | |||
| P2860 | cites work | Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy | Q26771690 |
| Systemic amyloidosis | Q30251986 | ||
| Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. | Q30493710 | ||
| Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. | Q31029305 | ||
| Incidence and survival in non-hereditary amyloidosis in Sweden | Q31106882 | ||
| Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens | Q33508070 | ||
| The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Q33695919 | ||
| Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study | Q33734406 | ||
| Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing | Q33769385 | ||
| Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study | Q33997173 | ||
| Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications. | Q34184698 | ||
| Guideline of transthyretin-related hereditary amyloidosis for clinicians. | Q34328734 | ||
| Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction | Q34414650 | ||
| Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction | Q34487487 | ||
| Systemic amyloidosis in England: an epidemiological study | Q34975379 | ||
| Hereditary transthyretin amyloidosis from a Scandinavian perspective. | Q35203818 | ||
| A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue | Q35552353 | ||
| Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | Q36165179 | ||
| Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements | Q36910372 | ||
| Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). | Q37083158 | ||
| The changing face of AA amyloidosis: a single center experience | Q58184891 | ||
| Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis | Q62083154 | ||
| Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee | Q64360477 | ||
| Symptomatic conduction system disease in cardiac amyloidosis | Q73943156 | ||
| Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts | Q74582113 | ||
| Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy | Q86245150 | ||
| Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis | Q90324651 | ||
| First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan | Q90912652 | ||
| Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging | Q91476754 | ||
| Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis | Q91501576 | ||
| Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis | Q91744230 | ||
| Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice | Q91852198 | ||
| Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis | Q92165412 | ||
| Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis | Q92176428 | ||
| Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography | Q92364969 | ||
| Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) | Q92781118 | ||
| High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis | Q92856025 | ||
| Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT | Q92898090 | ||
| Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene | Q37164492 | ||
| Echocardiographic assessment of the cardiac amyloidoses | Q38376077 | ||
| Magnetic Resonance in Transthyretin Cardiac Amyloidosis | Q38400944 | ||
| Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement | Q38411685 | ||
| Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. | Q38414834 | ||
| Native T1 mapping in transthyretin amyloidosis | Q38442488 | ||
| Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. | Q38452328 | ||
| Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study | Q38456041 | ||
| AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy | Q38955782 | ||
| Apolipoprotein A-I: the dual face of a protein. | Q38993412 | ||
| Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis | Q39169812 | ||
| Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis | Q39217713 | ||
| Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System | Q39431661 | ||
| Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). | Q40097698 | ||
| A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir. | Q40214126 | ||
| Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy | Q40388294 | ||
| Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans | Q40784560 | ||
| Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness | Q41149554 | ||
| A practical approach to the diagnosis of systemic amyloidoses. | Q41505050 | ||
| Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role | Q41724575 | ||
| Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease | Q41847394 | ||
| Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis. | Q41924604 | ||
| Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. | Q43598098 | ||
| Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989 | Q44353289 | ||
| Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice | Q46406608 | ||
| Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study | Q46645719 | ||
| Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis | Q46652184 | ||
| Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis | Q46902810 | ||
| Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis | Q47128372 | ||
| Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress | Q47882082 | ||
| Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging | Q48097450 | ||
| 11C-Pittsburgh B PET imaging in cardiac amyloidosis | Q48415403 | ||
| Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR). | Q48504995 | ||
| Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study | Q48590553 | ||
| Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. | Q48771344 | ||
| Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography | Q48793534 | ||
| Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement | Q50093215 | ||
| A new staging system for cardiac transthyretin amyloidosis | Q50094739 | ||
| Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis | Q50132614 | ||
| Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. | Q50212765 | ||
| Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy. | Q50616776 | ||
| Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. | Q50622497 | ||
| Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. | Q51084760 | ||
| Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. | Q51839511 | ||
| Different NT-proBNP circulating levels for different types of cardiac amyloidosis. | Q52144799 | ||
| Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography. | Q53065543 | ||
| Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. | Q54337852 | ||
| Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure | Q56349722 | ||
| Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy | Q56986496 | ||
| Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine | Q58030328 | ||
| P304 | page(s) | 100519 | |
| P577 | publication date | 2020-04-27 | |
| P1433 | published in | International Journal of Cardiology. Heart & vasculature | Q27726206 |
| P1476 | title | Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist | |
| P478 | volume | 28 |
| Q101038925 | Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis | cites work | P2860 |
Search more.